| First Author | Gurczynski SJ | Year | 2019 |
| Journal | Mucosal Immunol | Volume | 12 |
| Issue | 2 | Pages | 518-530 |
| PubMed ID | 30498200 | Mgi Jnum | J:295499 |
| Mgi Id | MGI:6453887 | Doi | 10.1038/s41385-018-0106-4 |
| Citation | Gurczynski SJ, et al. (2019) CCR2 mediates increased susceptibility to post-H1N1 bacterial pneumonia by limiting dendritic cell induction of IL-17. Mucosal Immunol 12(2):518-530 |
| abstractText | Post influenza bacterial pneumonia is associated with significant mortality and morbidity. Dendritic cells (DCs) play a crucial role in host defense against bacterial pneumonia, but their contribution to post influenza-susceptibility to secondary bacterial pneumonia is incompletely understood. WT and CCR2(-/-) mice were infected with 100 plaque forming units (pfu) H1N1 intranasally alone or were challenged on day 5 with 7 x 10(7) colony forming units (cfu) methicillin-resistant Staphylococcus aureus intratracheally. WT mice express abundant CCL2 mRNA and protein post-H1N1 alone or dual infection. CCR2(-/-) mice had significantly higher survival as compared to WT mice, associated with significantly improved bacterial clearance at 24 and 48 h (10-fold and 14-fold, respectively) post bacterial challenge. There was robust upregulation of IL-23 and IL-17 as well as downregulation of IL-27 expression in CCR2(-/-) mice following sequential infection as compared to WT mice, which was also associated with significantly greater accumulation of CD103(+) DC. Finally, WT mice treated with a CCR2 inhibitor showed improved bacterial clearance in association with similar cytokine profiles as CCR2(-/-) mice. Thus, CCR2 significantly contributes to increased susceptibility to bacterial infection after influenza pneumonia likely via altered dendritic cell responses and thus, CCR2 antagonism represents a potential therapeutic strategy. |
